Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shyam Kottilil

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Indian Journal of Experimental Biology|August 31, 2004
Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infectionShyam Kottilil
Gastroenterology Clinics of North America|May 12, 2020
Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and PreventionAmeer Abutaleb, Shyam Kottilil
Hepatology International|November 11, 2014
Mechanisms of alcohol-induced hepatocellular carcinomaSreetha Sidharthan, Shyam Kottilil
Frontiers in Medicine|November 25, 2021
Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and ManagementArshi Khanam, Shyam Kottilil
International Journal of Molecular Sciences|January 8, 2023
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?Arshi Khanam, Shyam Kottilil
Frontiers in Immunology|October 29, 2020
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for TherapeuticsArshi Khanam, Shyam Kottilil
Frontiers in Immunology|November 2, 2020
Immune Correlates of COVID-19 ControlBhawna Poonia, Shyam Kottilil
Future Virology|October 14, 2014
Strategies to eliminate HBV infectionRama Kapoor, Shyam Kottilil
Therapeutic Advances in Chronic Disease|January 2, 2015
Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis CKaroll J Cortez, Shyam Kottilil
Hepatology International|May 31, 2018
Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapyAmeer Abutaleb, Shyam Kottilil, Eleanor Wilson
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Indian Journal of Experimental Biology|August 31, 2004
Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infectionShyam Kottilil
Gastroenterology Clinics of North America|May 12, 2020
Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and PreventionAmeer Abutaleb, Shyam Kottilil
Hepatology International|November 11, 2014
Mechanisms of alcohol-induced hepatocellular carcinomaSreetha Sidharthan, Shyam Kottilil
Frontiers in Medicine|November 25, 2021
Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and ManagementArshi Khanam, Shyam Kottilil
International Journal of Molecular Sciences|January 8, 2023
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?Arshi Khanam, Shyam Kottilil
Frontiers in Immunology|October 29, 2020
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for TherapeuticsArshi Khanam, Shyam Kottilil
Frontiers in Immunology|November 2, 2020
Immune Correlates of COVID-19 ControlBhawna Poonia, Shyam Kottilil
Future Virology|October 14, 2014
Strategies to eliminate HBV infectionRama Kapoor, Shyam Kottilil
Therapeutic Advances in Chronic Disease|January 2, 2015
Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis CKaroll J Cortez, Shyam Kottilil
Hepatology International|May 31, 2018
Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapyAmeer Abutaleb, Shyam Kottilil, Eleanor Wilson
Pageof 18